Everand Logo

Welcome to Everand!

  • Newsweek

    Atomwise's Abraham Heifets Uses AI to Speed the Development of Medications

    Abraham Heifets is using artifical intelligence to ensure the safety of cancer patients while they undergo treatment.
    by Noah Miller Jul 26, 2019 3 minutes
    FE_Cancer_Moonshot
    FE_Cancer_Moonshot

    Abraham Heifets is the CEO and co-founder of Atomwise, a biotech company using patented deep learning artificial intelligence technology to predict and discover which drugs will be better, safer and more potent for cancer patients.

    What is your moonshot? To make novel, better and safer drugs, with the ultimate goal to get medicines into the hands of patients faster.

    How do you do that? We're trying to solve how you modify a cell that's in the runaway

    You’re reading a preview, subscribe to read more.

    More from Newsweek

    Newsweek3 min read
    Newsweek US
    GLOBAL EDITOR IN CHIEF _ Nancy Cooper EXECUTIVE EDITOR _ Jennifer H. Cunningham VICE PRESIDENT, DIGITAL _ Laura Davis DIRECTOR OF OPERATIONS _ Melissa Jewsbury OPINION EDITOR _ Batya Ungar-SargonGLOBAL PUBLISHING EDITOR _ Chris Roberts SENIOR EDITOR-
    Newsweek1 min read
    Living On The Edge
    An 18th-century cottage clings to the precipice following a dramatic cliff fall in the coastal village of Trimingham on April 8. The homeowner, who bought the property in 2019 for around $165,000, will now see the structure demolished as the saturate
    Newsweek1 min read
    The Archives
    “After the bloody steps, the heart-rending funerals, the surreal chase through the twilight of Los Angeles, O.J. Simpson surrendered himself into the darkness his life has become,” Newsweek wrote after the famous white Ford Bronco chase on a Californ

    Related Books & Audiobooks